Trial of Magrolimab (Hu5F9-G4) in Combination With Rituximab or Rituximab + Chemotherapy in Participants With Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma
Gilead Sciences
Gilead Sciences
Masonic Cancer Center, University of Minnesota
Goethe University
National Institute of Allergy and Infectious Diseases (NIAID)
National Institute of Allergy and Infectious Diseases (NIAID)
Massachusetts General Hospital
Alliance for Clinical Trials in Oncology
University of New Mexico